GENETIC TECHNOLOGIES LIMITED

0.00%

3.9¢

Market Cap $52.08M

Healthcare Medical Care

Genetic Technologies Limited is an Australia-based diversified molecular diagnostics... Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company's segments include EasyDNA and AffinityDNA. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

Latest Threads

Tag

Subject

GTG

Ann: Long Term Suspended Entities

16/07/25

282

16/07/25

Last post

ASX News

282

GTG

Ann: Binding Term Sheets Executed

05/07/25

1.4K

05/07/25

Last post JenniferEV

1.4K

GTG

Ann: Change of Auditor

30/06/25

238

30/06/25

Last post

ASX News

238

GTG

Ann: Notification of cessation of securities - GTG

23/05/25

374

23/05/25

Last post

ASX News

374

GTG

Ann: Notification of cessation of securities - GTG

23/05/25

274

23/05/25

Last post

ASX News

274

GTG

Ann: Change in substantial holding

22/05/25

301

22/05/25

Last post

ASX News

301

GTG

Ann: Becoming a substantial holder

21/05/25

246

21/05/25

Last post

ASX News

246

GTG

Ann: Initial Director's Interest Notice x2

21/05/25

213

21/05/25

Last post

ASX News

213

See All Discussions

Timeline

Long Term Suspended Entities
16 Jul 16:15	Share

Change of Auditor
30 Jun 14:44	Share

Binding Term Sheets Executed
06 Jun 14:42	Share

Notification of cessation of securities - GTG
23 May 12:40	Share

Notification of cessation of securities - GTG
23 May 12:36	Share

Change in substantial holding
22 May 08:18	Share

Becoming a substantial holder
21 May 14:41	Share

Initial Director's Interest Notice x2
21 May 14:10	Share

Application for quotation of securities - GTG
21 May 14:05	Share

Application for quotation of securities - GTG
21 May 13:59	Share

Change of Registered Office Address
15 May 09:33	Share

Final Director's Interest Notice
15 May 09:32	Share

Update on Board and Executive Changes
15 May 09:32	Share

Effectuation of Deed of Company Arrangement
14 May 14:08	Share

Initial Director's Interest Notice x2
14 May 14:01	Share

Final Director's Interest Notice x 3
14 May 13:10	Share

Proposed issue of securities - GTG
14 May 13:02	Share

Proposed issue of securities - GTG
14 May 13:02	Share

Director Appointment/Resignation
14 May 12:52	Share

Results of General Meeting
14 May 12:52	Share

Notice of General Meeting
16 Apr 08:34	Share

Long Term Suspended Entities
09 Apr 16:18	Share

Letter to Shareholders
24 Mar 11:47	Share

Creditors resolve to execute Benelong DOCA
28 Feb 16:45	Share

Change of registered office address
24 Feb 11:43	Share

Resumption of Reconvened Meeting of Creditors
21 Feb 13:02	Share

Notice of Reconvened Second Meeting of Creditors
13 Feb 12:59	Share

Notice of Reconvened Second Meeting of Creditors
05 Feb 12:24	Share

Long Term Suspended Entities
22 Jan 16:20	Share

GTG sells Affinity/EasyDNA businesses
20 Jan 10:05	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.9¢		Change 0.000(0.00%)		Mkt cap ! $52.08M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

GTG (ASX) Chart

Day chart unavailable

GENETIC TECHNOLOGIES LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

Genetic Tech boosts reach of the geneType risk tests in 42 countries with global launch

Genetic Technologies Ltd has announced the global launch of its geneType risk tests on the EasyDNA platform.

Genetic Technologies say geneType tests identify 79.5% of people with elevated risk of disease

Genetic Technologies Ltd says its geneType Multi-Risk tests have shown 79.5% of those tested to have an elevated risk of disease.

Genetic Technologies kicks off US breast cancer imaging campaign

Genetic Technologies has announced its launch of a breast cancer imaging program across three US clinics in NY, Miami and Houston, Texas.

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

A new NASDAQ listing for a key player in the global critical minerals space

Top Stories

Featured News